CAAS CAPITAL MANAGEMENT LP: MRNA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAAS CAPITAL MANAGEMENT LP on MRNA, newest first. How the timeline and the estimate are built.
CAAS CAPITAL MANAGEMENT LP held 0 MRNA shares at 2024-12-31 per its 13F-HR filed 2025-01-24.
the latest 13F is the newest step
- period ended2024-12-3113F 0 sharesChange vs previous 13F -11,812 shares
13F-HR 0001085146-25-000475 filed by CAAS CAPITAL MANAGEMENT LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-09-3013F 11,812 sharesChange vs previous 13F +8,504 shares
0.54% of the 13F portfolio, value $789,396.
13F-HR 0001085146-24-005188 filed by CAAS CAPITAL MANAGEMENT LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-06-3013F 3,308 sharesChange vs previous 13F +308 shares
0.73% of the 13F portfolio, value $392,825.
13F-HR 0001085146-24-002970 filed by CAAS CAPITAL MANAGEMENT LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-03-3113F 3,000 sharesChange vs previous 13F -1,500 shares
0.14% of the 13F portfolio, value $319,680.
13F-HR 0001085146-24-002075 filed by CAAS CAPITAL MANAGEMENT LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-12-3113F 4,500 sharesChange vs previous 13F not available
0.42% of the 13F portfolio, value $447,525.
13F-HR 0001085146-24-001311 filed by CAAS CAPITAL MANAGEMENT LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).